ANTHOGYR SAS

Their core work

Anthogyr is a French dental and medical implant manufacturer based in Sallanches, specializing in the design and production of implant systems, surgical instruments, and prosthetic components. Within H2020, they contributed industrial expertise in ceramic and metallic implant fabrication, serving as a bridge between materials research and commercial implant production. Their projects focus on improving implant safety through advanced ceramics, additive manufacturing techniques, and biofilm-resistant surface engineering. As an established implant company, they bring real manufacturing capacity and regulatory knowledge to research consortia.

What they specialise in

How they've shifted over time

Anthogyr's H2020 trajectory shows a clear shift from ceramic implant fabrication toward biologically active surface engineering. Their early work (2017) centered on ceramic-based smart implants through SISCERA, where they led as coordinator. By 2020, their focus expanded into antibacterial coatings, metallic biomaterials, and nanostructured surfaces through BIOREMIA, reflecting a broader industry trend toward infection-resistant implant technologies.

Anthogyr is moving from pure implant fabrication toward biofunctional surfaces and infection prevention — expect future interest in antimicrobial coatings and smart implant monitoring.

How they like to work

Anthogyr balances leadership and partnership roles, having coordinated one project (SISCERA) while participating in two others. With 33 unique partners across 12 countries, they operate in medium-to-large consortia and appear comfortable working within broad international research networks. Their participation in two MSCA projects (RISE and ITN) suggests they value researcher mobility and training partnerships, positioning themselves as an industrial host for academic collaborators.

Anthogyr has built a network of 33 partners across 12 countries, indicating strong European reach for a company of its size. Their MSCA involvement connects them primarily to university research groups and training networks across the EU.

What sets them apart

Anthogyr brings something rare to research consortia: they are not a lab or university but an actual implant manufacturer with production lines, regulatory experience, and market access. This means research results developed in partnership with them have a realistic path to commercial products. For academics seeking an industrial partner who can validate, prototype, and eventually manufacture biomedical implants, Anthogyr is a credible and proven choice in the French Alps medical devices cluster.

Highlights from their portfolio

• SISCERA
  Their only coordinator role with the largest budget (EUR 983,841), focused on ceramic implant safety — signals this as their core strategic R&D priority.
• BIOREMIA
  A 4-year MSCA training network on biofilm-resistant implants, placing Anthogyr at the center of next-generation anti-infection implant research with substantial funding (EUR 274,802).